According to Zacks, “Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York. “
Shares of Q BioMed (NASDAQ:QBIO) opened at 4.51 on Wednesday. The firm’s market capitalization is $40.00 million. Q BioMed has a 12-month low of $1.26 and a 12-month high of $6.00. The company’s 50-day moving average price is $3.61 and its 200 day moving average price is $3.21.
About Q BioMed
Q BioMed, Inc, formerly ISMO Tech Solutions, Inc, is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Q BioMed Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed Inc and related companies with MarketBeat.com's FREE daily email newsletter.